Merck | MRK - Sales Revenues


Merck reported EUR5.43B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Adidas EUR 7.25B 510M Sep/2026
Adyen EUR 1.46B 37.58M Jun/2026
Akzo Nobel EUR 2.54B 52M Sep/2026
Alcon AG USD 2.72B 60M Sep/2026
Amadeus IT EUR 1.74B 90M Sep/2026
Amarin USD 49.22M 451K Dec/2025
AstraZeneca USD 16.21B 830M Sep/2026
BASF EUR 16.36B 850M Sep/2026
Bayer EUR 10.05B 820M Sep/2026
Beiersdorf EUR 2.4B 50M Sep/2026
Covestro EUR 6.73B 3.82B Jun/2026
Danone EUR 7.22B 510M Jun/2026
Fresenius EUR 5.88B 70M Sep/2026
Fresenius Medical Care EUR 4.94B 80M Sep/2026
Genmab DKK 1.16B 259M Jun/2026
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 8.89B 480M Sep/2026
GRIFOLS EUR 2.04B 170M Sep/2026
Henkel EUR 10.35B 255M Jun/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Infineon EUR 4.71B 540M Sep/2026
Lakefront Biotherapeutics EUR 7.11M 5M Sep/2026
Linde USD 9.4B 623M Sep/2026
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.43B 300M Jun/2026
Novartis USD 14.52B 112M Sep/2026
Philips EUR 4.4B 40M Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 14.44B 2.49B Sep/2026
UCB EUR 4.25B 764M Dec/2025